Black checkmark with a sparkle and a curved line underneath on a white background.
Company

Healthcare Triangle, Inc.

Ticker
HCTI
Sector
Industry
Report date
November 13, 2026
Valye AI Score

93

Very high visibility
Recent developments
Recent developments summary

Recent developments include strategic acquisitions, partnerships, a new AI platform launch, and a reverse stock split approved by stockholders.

Recent developments:
  • Healthcare Triangle announced a 1-for-20 reverse stock split in October 2026 following stockholder approval of a reverse split range from 1:2 to 1:25 [N1][N2].
  • The company signed a Letter of Intent to acquire Roboticom assets for up to $30 million in September 2026 [N4].
  • Healthcare Triangle signed an agreement to acquire Teyame AI's customer experience platforms in January 2026 [N3].
  • The company launched an Agentic AI platform for healthcare services in March 2026 [N6].
  • Healthcare Triangle entered a partnership with QuantumNexis-TNG in February 2026 [N7].
Overview

Healthcare Triangle, Inc. is a Delaware-based healthcare technology company listed on Nasdaq under ticker HCTI. The company develops AI-driven platforms and healthcare services technology. It has engaged in strategic acquisitions and partnerships to expand its offerings, including agreements to acquire Roboticom assets and Teyame AI's customer experience platforms. The company launched an Agentic AI platform for healthcare services in early 2026. As of late 2026, Healthcare Triangle announced a reverse stock split approved by stockholders to adjust its share structure. The company reported quarterly revenue of $9.116 million but incurred a net loss of $2.532 million, with liquidity ratios below 1, indicating current liabilities exceed current assets. The company has accumulated deficits and outstanding convertible preferred stock. The 2025 annual report disclosed substantial doubt about the company's ability to continue as a going concern due to ongoing losses and negative operating cash flows [S1][S2][N1][N2][N3][N4][N6][N7].

Executive summary

Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. Healthcare Triangle, Inc. is a healthcare technology company with recent strategic moves including acquisitions and AI platform launches. The company reported $9.116 million in revenue and a net loss of $2.532 million for the quarter ended September 30, 2026, with liquidity ratios indicating current liabilities exceed current assets. Recent news highlights include a reverse stock split and multiple partnership and acquisition agreements [S2][N1][N2][N3][N4][N6][N7].

Scenarios for HCTI

Bull case model:

The company has demonstrated active strategic initiatives including launching an Agentic AI platform for healthcare services and signing agreements to acquire complementary technology assets. These moves could enhance its product portfolio and market presence. Partnerships such as the QuantumNexis-TNG collaboration indicate efforts to expand capabilities and reach. The reverse stock split may improve stock liquidity and market perception. If operational execution improves, these factors could support business growth and technology leadership.

Bear case model:

Healthcare Triangle has reported net losses and negative cash flows, with liquidity ratios indicating current liabilities exceed current assets. The company has accumulated deficits and relies on equity or other financing to fund operations, raising going concern risks. The reverse stock split may reflect attempts to address stock price challenges. Execution risks include integration of acquisitions, achieving profitability, and managing liquidity constraints. Failure to improve financial health or operational performance could impair business sustainability.

Moat:

Healthcare Triangle's moat appears to be based on its specialized AI healthcare technology platforms and strategic acquisitions that enhance its service offerings. The company's focus on healthcare AI and customer experience platforms, combined with partnerships and acquisitions, may provide competitive differentiation. However, the company faces challenges related to profitability and liquidity, which may impact its ability to sustain competitive advantages without additional financing or operational improvements.

Risks overview
Risks summary
The primary risk for Healthcare Triangle is its liquidity and going concern status due to ongoing losses and current liabilities exceeding current assets, which could affect its operational continuity and ability to execute strategic initiatives.
Risks details:

• Liquidity and Going Concern Risk: The company has negative cash flows from operations and current liabilities exceed current assets, raising substantial doubt about its ability to continue as a going concern [S1][S2].
• Profitability Risk: Healthcare Triangle reported a net loss of $2.532 million for the quarter ended September 30, 2026, and has accumulated deficits, indicating ongoing challenges in achieving profitability [S2][S1].
• Execution Risk on Acquisitions and Partnerships: The company has signed agreements to acquire Roboticom assets and Teyame AI platforms, which require successful integration and realization of expected benefits [N3][N4].
• Stock Structure and Market Perception: The recent 1-for-20 reverse stock split approved by stockholders may impact stock liquidity and investor perception [N1][N2].

FINAL FORECAST FOR HCTI

Final take one line
Healthcare Triangle, Inc. shows very high visibility with detailed SEC filings and recent strategic developments, but faces liquidity and profitability challenges.
Final take 12 to 24 month view

Business trends: The company is actively expanding its healthcare AI and technology platform offerings through acquisitions and partnerships, including launching new AI platforms and signing LOIs for asset acquisitions.
Execution milestones: Key milestones include the launch of the Agentic AI platform, partnership with QuantumNexis-TNG, acquisition agreements for Roboticom and Teyame AI platforms, and completion of a reverse stock split.
Key risks: Liquidity constraints and ongoing net losses raise going concern risks; successful integration of acquisitions and operational execution remain critical.

Valye AI Visibility Research Score

Very high visibility

Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).

93
LLM visibility overview
LLM Visibility known facts
  • Healthcare Triangle, Inc. is a Delaware corporation headquartered in Pleasanton, California, listed on Nasdaq under ticker HCTI [S1].
  • As of December 31, 2025, the company had 1,967,588 shares of common stock issued and outstanding [S1].
  • The company operates in healthcare-related technology services, including AI platforms for healthcare services [N6].
  • Healthcare Triangle launched an Agentic AI platform for healthcare services in March 2026 [N6].
  • The company signed a Letter of Intent (LOI) to acquire Roboticom assets for up to $30 million in September 2026 [N4].
  • Healthcare Triangle signed an agreement to acquire Teyame AI's customer experience platforms in January 2026 [N3].
  • The company entered a partnership with QuantumNexis-TNG in February 2026 [N7].
  • Healthcare Triangle announced a 1-for-20 reverse stock split in October 2026, approved by stockholders with a range of 1:2 to 1:25 [N1][N2].
  • Financial figures as of September 30, 2026, include cash and equivalents of $1.869 million, current assets of $8.862 million, current liabilities of $14.383 million, and revenue of $9.116 million for the quarter [S2].
  • The company reported a net loss of $2.532 million for the quarter ended September 30, 2026 [S2].
  • Basic earnings per share were $1.70 and diluted EPS was $1.21 for the quarter ended September 30, 2026 [S2].
  • Liquidity ratios as of September 30, 2026, show a current ratio of 0.62 and a cash ratio of 0.13, indicating current liabilities exceed current assets [S2].
  • The company has yet to achieve profitable operations and has negative cash flows from operating activities, raising substantial doubt about its ability to continue as a going concern as disclosed in the 2025 annual report [S1].
  • The company has issued Series B Convertible preferred stock and has accumulated deficits as of December 31, 2025 [S1].
Sources
Sources - Context summary

Generated 2026-11-14

Sources - Earning calls
Sources - Other context
Sources - SEC Filings
  • S1 | 2026-04-16 | 10-K/A
  • S2 | 2026-11-13 | 10-Q
Sources - News headlines
  • N1 | 2026-10-28 | www.nasdaq.com | Healthcare Triangle, Inc. Announces 1-for-20 Reverse Stock Split | https://www.nasdaq.com/articles/healthcare-triangle-inc-announces-1-20-reverse-stock-split
  • N2 | 2026-10-24 | www.nasdaq.com | Healthcare Triangle, Inc. Stockholders Approve Reverse Stock Split Range of 1:2 to 1:25 at Special Meeting on October 23, 2026 | https://www.nasdaq.com/articles/healthcare-triangle-inc-stockholders-approve-reverse-stock-split-range-1-2-1-25-special
  • N3 | 2026-09-25 | www.nasdaq.com | Weekly Buzz: MESO, LLY, ANIP Win FDA Nod; KALA, HCTI Sign LOI; IMVT Halts Lupus Study | https://www.nasdaq.com/articles/weekly-buzz-meso-lly-anip-win-fda-nod-kala-hcti-sign-loi-imvt-halts-lupus-study
  • N4 | 2026-09-24 | www.nasdaq.com | Healthcare Triangle Signs LOI To Acquire Roboticom Assets For Up To $30 Mln; Stock Down | https://www.nasdaq.com/articles/healthcare-triangle-signs-loi-acquire-roboticom-assets-30-mln-stock-down
  • N5 | 2026-08-14 | www.nasdaq.com | Top Biotech Gainers: HCTI, LEXX, LNSR, JUNS, OMER, AVAH... | https://www.nasdaq.com/articles/top-biotech-gainers-hcti-lexx-lnsr-juns-omer-avah
  • N6 | 2026-03-26 | www.nasdaq.com | Healthcare Triangle Launches Agentic AI Platform For Healthcare Services, Stock Up | https://www.nasdaq.com/articles/healthcare-triangle-launches-agentic-ai-platform-healthcare-services-stock
  • N7 | 2026-02-26 | www.nasdaq.com | Healthcare Triangle Stock Jumps On QuantumNexis-TNG Partnership | https://www.nasdaq.com/articles/healthcare-triangle-stock-jumps-quantumnexis-tng-partnership
  • N8 | 2026-01-23 | www.nasdaq.com | Weekly Buzz: IOBT Slashes Jobs; GSK To Acquire RAPT; CORT's Ovarian Cancer Study Meets Goals | https://www.nasdaq.com/articles/weekly-buzz-iobt-slashes-jobs-gsk-acquire-rapt-corts-ovarian-cancer-study-meets-goals
Important legal disclaimer

This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Blue logo with a stylized checkmark and star above the blue text 'VALYE' on a black background.

Generated by Valye SEC Pipeline Engine